Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine

Acta Physiologica Scandinavica

Volumn 181, Issue 3, 2004, Pages 297-303

  Nandhini, A T A ^a   Thirunavukkarasu, V ^a   Anuradha, C V ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Advanced glycation end products; Diaphragm; Fructosamine; Fructose feeding; Glucose; Glucose utilization; Glycated haemoglobin; Taurine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; FRUCTOSAMINE; FRUCTOSE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED PROTEIN; INSULIN; TAURINE;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL FEEDING; CALORIC INTAKE; CONTROLLED STUDY; DIAPHRAGM; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT; STIMULATION;

ANIMALS; BLOOD GLUCOSE; DIAPHRAGM; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUCTOSAMINE; FRUCTOSE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; MALE; RATS; RATS, WISTAR; TAURINE;

EID: 3042822693     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2004.01287.x     Document Type: Article

References (41)

1. Anuradha, C.V. & Balakrishnan, S.D. 1999. Taurine attenuates hypertension and improves insulin sensitivity in the fructose fed rats, an animal model of insulin resistance. Can J Physiol Pharmacol 77, 1-6.
2. Banks, M.A., Porter, D.W., Martin, W.G. & Castranova, V. 1992. Taurine protects against oxidant injury to rat alveolar pneumocytes. In: J.B. Lombardini, S.W. Schaffer & J. Azuma (eds) Taurine: Nutritional Value and Mechanisms of Action, pp. 341-359. Plenum Press, New York and London.
3. Baynes, J.W. & Thorpe, S.R. 1999. Role of oxidative stress in diabetic complications - a new perspective of an old paradigm. Diabetes 48, 1-9.
4. Blakytny, R. & Harding, J.J. 1992. Prevention of cataract in diabetic rat by aspirin, paracetamol and ibuprofen. Exp Eye Res 54, 509-518.
5. Brownlee, M. 2000. Negative consequences of glycation. Metabolism 49(Suppl. 1), 9-13.
6. Bucala, R. 1999. Advanced glycosylation end products and diabetic vascular disease. In: J.F. Keaney Jr (ed.) Oxidative Stress and Vascular Disease, pp. 213-243. Kluwer Academic Publishers, Dordrecht.
7. Cuisinier, C., De Welle, J.M., Verbeeck, R.K. et al. 2002. Role of taurine in osmoregulation during endurance exercise. Eur J Appl Physiol 87, 489-495.
8. Devamanoharan, P.S., Ali, A.M. & Varma, S.D. 1997. Oxidative stress to rat lens in vitro: attenuation by taurine. Invest Ophthalmol Vis Sci 38, S1025.
9. Devamanoharan, P.S., Ali, A.M. & Varma, S.D. 1998. Prevention of lens protein glycation by taurine. Mol Cell Biochem 177, 245-250.
10. Di Leo, M.A., Santini, S.A., Gereone, S. et al. 2002. Chronic taurine supplementation ameliorates oxidative stress and Na (+) K (+) ATPase impairment in the retina of diabetic rats. Amino Acids 23, 401-406.
11. Dokshina, G.A., Yu-Silaeva, T. & Yartsev, E.I. 1976. Some insulin-like effects of taurine. Vopr Med Khim 22, 503-507.
12. Edelstein, D. & Brownlee, M. 1992. Mechanistic studies of advanced glycation end product inhibition by aminoguanidine. Diabetes 41, 26-29.
13. Franconi, F., Bennardini, F., Mattama, A. et al. 1995. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61, 1115-1119.
14. Gandhi, V.M. & Mulky, M.J. 1990. Some pharmacological studies on taurine. Ind J Pharmacol 22, 128-132.
15. Goodman, H.O. & Shibabi, Z.K. 1990. Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides. Biochem Med Metabol Biol 43, 1-9.
16. Haber, C.A., Lam, T.K., Yu, Z. et al. 2003. N-acetylcysteine (NAC) and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am J Physiol Endocrinol Metab 285, 744-753.
17. Hansen, S.H. 2001. The role of taurine in diabetes and the development of diabetic complications. Diab Metabol Res Rev 17, 330-346.
18. Haugaard, N. & Haugaard, S.E. 1970. Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro. Biochim Biophys Acta 222, 583-586.
19. Hunt, J.V., Skamarauskas, J.T. & Mitchinson, M.J. 1994. Protein glycation and fluorescent material in human atheroma. Atherosclerosis 11, 255-265.
20. Huxtable, R.J. 1992. Physiological actions of taurine. Physiol Rev 75, 101-163.
21. Jakus, V., Bauerova, K., Michalkova, D. & Carsky, J. 2000. Value of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus. Bratisl Lek Listy 101, 484-489.
22. Johnson, R.N., Metealf, P.A. & Baker, J.R. 1983. Fructosamine: a new approach to the estimation of serum glycosylation. An index of diabetic control. Clin Chim Acta 217, 87-95.
23. Kulakowshi, E.C. & Maturo, J. 1984. Hypoglycemic properties of taurine not mediated by enhanced insulin release. Biochem Pharmacol 33, 2835-2838.
24. Le Guen, C.A., Jones, A.F., Barnett, A.M. & Lunec, L. 1992. Role of reactive oxygen species on the generation of fluorescence by glycation. Ann Clin Biochem 29, 184-189.
25. Michalk, D.V., Wingenfeld, P. & Licht, C.H. 1997. Protection against cell damage due to hypoxia and reoxygenation: the role of taurine and the involved mechanisms. Amino Acids 13, 337-346.
26. Mullarkey, C.J., Edelstein, D. & Brownlee, M. 1990. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochim Biophys Res Commun 173, 932-939.
27. Nandhini, A.T.A. & Anuradha, C.V. 2002. Taurine modulates kallikrein activity and glucose metabolism in insulin-resistant rats. Amino Acids 22, 27-38.
28. Nandhini, A.T.A. & Anuradha, C.V. 2003. Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose. Clin Chim Acta 336, 129-135.
29. Obrosova, I.G., Fathallah, L. & Stevens, M.J. 2001. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp Neurol 172, 211-219.
30. Ogasawara, M., Nakamura, T., Koyama, I., Nemoto, M. & Yashida, T. 1994. Reactivity of taurine with aldehydes and its physiological role. Adv Exp Biol Med 359, 71-78.
31. Rao, P. & Pattabiraman, T.N. 1990. Further studies on the mechanism of phenol sulfuric acid reaction with furfur-aldehyde derivatives. Anal Biochem 189, 178-181.
32. Sasaki, T., Matsui, S. & Sonae, A. 1972. Effect of acetic acid concentration on the colour reaction in the o-toluidine boric acid method for blood glucose estimation. Rinshokagaku 1, 346-353.
33. Schalkwijk, C.G., Ligtvoet, N., Twaalhofen, H. et al. 1999. Amadori albumin in type 1 diabetic patients. Correlation with markers of endothelial function, association with diabetic nephropathy and localization in retinal capillaries. Diabetes 48, 2446-2453.
34. Stitt, A.W. 2001. Advanced glycation: an important pathological event in diabetic and age-related ocular disease. Br J Opthalmol 85, 746-753.
35. Trachtman, H., Del Pizzo, R. & Futterweit, S. et al. 1992. Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am J Physiol 262, F117-F123.
36. Turk, Z. 1997. Advanced glycation toxicity and diabetic complications. Diabetol Croat 26, 11-26.
37. Vinson, A.J. & Howard, B.T. 1996. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem 7, 659-663.
38. Vlassara, H., Bucala, R. & Striker, L. 1994. Pathogenic effect of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. J Lab Invest 70, 138-151.
39. Wolff, S.P., Jiang, X.Y. & Hunt, J.V. 1991. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Rad Biol Med 10, 339-352.
40. Wu, Q.D., Wang, J.H., Fennessy, F., Redmond, H.P. & Bouchier-Hayes, D. 1999. Taurine prevents high glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 277, C1229-C1238.
41. Yanagisawa, K., Makita, Z., Shiroshita, K. et al. 1998. Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism 47, 1348-1353.